• No results found

Diagnostics and Monitoring of COVID-19 Infection – Current Understanding

N/A
N/A
Protected

Academic year: 2020

Share "Diagnostics and Monitoring of COVID-19 Infection – Current Understanding"

Copied!
28
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1. Temporal development of viral RNA detection in different biological samples
Figure 3. Time-dependent COVID-19 diagnostics by combined molecular and serologic tests

References

Related documents

The test procedure and the interpretation of result must be followed closely when testing for the presence of SARS-CoV-2 virus specific antibodies in the whole blood, serum, or

Among all chosen samples, Artron COVID-19 IgM/IgG Antibody identified out total 145 SARS-COV-2 IgM&/or IgG positive include 121 IgM positive and 93 IgG positive from 174

Moderna COVID-19 vaccine SARS-CoV-2 (COVID-19) vaccine / mRNA-1273 0.2 MG/ML Injectable Suspension 37003518 Pfizer-Biontech COVID-19 Vaccine SARS-CoV- (COVID-19) vaccine /

Le test rapide GENLISA™ Anti-SARS-Cov-2 (Covid-19) est utilisé pour la détection qualitative de l’anticorps Corona Virus-IgG/IgM dans le sérum, le plasma et le sang

In this work we detect S1 IgG antibodies up to 147 days post- infection on average, in all participants of the second sample and up to 314 days in a severe case of COVID-19 of

10 Uwe Wannags Hard Software Distribution eK Account systemroot system32 config systemprofile AppData Local Microsoft Windows Temporary Internet Files folder emptied 55347

ANCC Accredited Providers (Provider Units) must establish quality outcome (QO) measures that are used to evaluate performance of the Provider Unit as an entity and to evaluate

COVID-19 Death: COVID-19 death is defined for surveillance purposes as a death resulting from a clinically compatible illness in a probable or confirmed COVID-19 case, unless there